BioSpace News Archive

Top-line Data Anticipated in the Fourth Quarter of 2019

Only Radiotherapy System with Helical Delivery Capability and Intrafraction Motion Synchronization Functionality, Offering Expanded Versatility and Increased Precision in the Treatment of Simple to Complex Tumors

CytoSorbents Corporation shares highlights from the recent 6th International CytoSorb Users’ Meeting and the Satellite Symposium at the 39th International Symposium on Intensive Care and Emergency Medicine in Brussels, Belgium, and the 8th Annual EuroELSO 2019 Conference held recently in Barcelona, Spain.

Industry leaders to discuss the impact of advanced innovation on commercial models and driving improved patient outcomes

Arrowhead Pharmaceuticals Inc. announced that it has begun dosing in a new triple combination cohort (cohort 12) that includes JNJ-3989 (formerly ARO-HBV) and additional undisclosed agents selected by Janssen Pharmaceuticals, Inc. in its ongoing Phase 1/2 study (AROHBV1001) in patients with chronic hepatitis B virus (HBV).

MDxHealth SA, a commercial-stage innovative molecular diagnostics company, provided a business update for the first quarter ended March 31, 2019.

Nine out of ten mothers in peak childbearing years say technology to protect women and babies during L&D would influence decision about where to give birth

Medical Diagnostics Company Aims to Improve Efficacy of Platelet Transfusions

MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States

Bausch Health Companies Inc. announced that the Company will participate in four investor conferences in May.